The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
about
Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Treatment of psychosis and dementia in Parkinson's disease.A clinical profile of patients with Parkinson's disease and psychosis.Parkinson's disease: the quintessential neuropsychiatric disorderTreatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptomsTrigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort studyNeuropsychiatric co-morbidities in non-demented Parkinson's disease.An update expert opinion on management and research strategies in Parkinson's disease psychosisCerebral correlates of psychotic syndromes in neurodegenerative diseasesPrevalence of psychotic symptoms in a community-based Parkinson disease sampleFeeling of presence in Parkinson's disease.Altered functional connectivity in lesional peduncular hallucinosis with REM sleep behavior disorder.Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease.Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control studyNeuropsychiatric symptoms in untreated Parkinson's disease.Nonmotor symptoms in Parkinson's disease.Taking a better history for behavioral issues pre- and post-deep brain stimulation: issues missed by standardized scales.Drug treatments for the neuropsychiatric complications of Parkinson's disease.Psychiatric issues in cognitive impairment.Are patients with Parkinson's disease blind to blindsight?Novel pharmaceuticals in the treatment of psychosis in Parkinson's disease.The psychosis spectrum in Parkinson disease.Pimavanserin: A Novel Antipsychotic for Parkinson's Disease Psychosis.Parkinson's disease psychosis: therapy tips and the importance of communication between neurologists and psychiatrists.Current Understanding of Psychosis in Parkinson's Disease.Psychosis in parkinsonism: an unorthodox approach.Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.Psychosis assessment in early-stage Parkinson's disease: comparing Parkinson's psychosis questionnaire with the brief psychiatric rating scale in a portuguese sample.Neuropsychiatric Symptoms in Parkinson's Disease: Beyond Complications.Management of Psychosis in Parkinson's Disease: Emphasizing Clinical Subtypes and Pathophysiological Mechanisms of the Condition.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Pimavanserin for the treatment of Parkinson's disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed.Prevalence of and indications for antipsychotic use in Parkinson's disease.Parkinson's disease psychosis: presentation, diagnosis and management.Clinical Practice Guideline for Management of Psychoses in Elderly.The prevalence and characteristics of hallucinations, delusions and minor phenomena in a non-demented population sample aged 60 years and over
P2860
Q30249553-53717C0C-A7AA-42E8-8E24-5614DACF297EQ30358337-AF793E5B-1AA3-474D-A3CB-9A84C518A687Q33877835-EDAE0024-7C15-452D-B6B3-E40DA4F92535Q33917094-6E64FACE-7197-4093-8DBC-D313147EB2ECQ34388686-DC134C16-F630-4B2E-97C3-13BFF9DA1E4DQ34638941-6D9D1B47-C061-4E59-83D3-2628A9B40FD8Q35016008-C919F708-EC5E-4A55-BBDC-1771B1D90D82Q35149177-148D490C-5979-48E4-8BF1-D36806AAF8CBQ35154278-AA39CCA0-0328-4C53-8EA8-842FE69C180FQ35194993-EFFFDE5F-6136-4194-B199-77F1EAD5EDCFQ35201060-77326675-2743-430A-8D65-6B93B16AA3BCQ36055737-81758C45-6526-489A-9B70-760BFBCCD02BQ36763240-B9568424-A815-43CD-8396-E2D8EF9B51CCQ37505818-CDA74FDD-F686-412A-A21F-5A7CEE6BC249Q37537915-6FF42D13-615D-43EC-A8A4-0B7F118BCEBFQ37714081-E6945C88-BEC4-42FC-89F9-E9B378C31F68Q37950422-8D90476A-9BD5-48DB-8F08-C9D6C3641243Q38022781-8ED015D0-7326-437D-8D13-9BDD67BE010DQ38067142-924929D4-CA6B-4A5F-A48E-1C2F3362087EQ38206498-A88E8540-BF92-4D85-9BC6-758A1C66E923Q38207009-89B65BE9-0DCF-41E9-B3DC-1402FBEAD10FQ38258699-0C9145AC-0620-4CB7-BD41-C597B1E37216Q38768169-6FFC8FCA-6062-4CBA-9B2B-A0223D27D8F3Q38856074-14704DD4-5F17-4953-87AB-F49051E50C78Q38894971-410272B7-8E72-41FA-AB7F-ED014FC1E107Q38954642-9CF8098A-2AB3-4850-BC3E-B82A27992B74Q39335522-4E07DD6F-A3BA-4C29-8011-F052D4EFFFA6Q40499334-4A3C0892-356B-4F3E-B2F2-6A3A3F18C53AQ42123038-07EFCB14-C542-4DE7-92C9-CCD9E856AF10Q42563680-5864808D-0A15-4C8C-B77D-FB4D3A95ECF4Q43375910-028048C3-53A7-4613-B767-D2248D326B81Q46354756-0FB6F8A8-6040-4803-9F42-DC240966D3D9Q46754794-B1E14857-D241-4DB4-BA70-B9CF8C94EB6BQ48349028-2AF3DE9F-9B7A-41F5-AAFF-C7405C4C23E6Q51781286-F415BE51-43AD-4023-8708-84160E0606A8Q55003552-26A1BDB0-F82C-451B-AF9C-92B88D5B71B9Q56787136-C5A61B66-D2F6-4E36-99BA-B7B63EB8546E
P2860
The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@ast
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@en
type
label
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@ast
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@en
prefLabel
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@ast
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@en
P2860
P356
P1433
P1476
The changing face of Parkinson ...... n the new NINDS-NIMH criteria.
@en
P2093
Gilles Fénelon
Thierry Soulas
P2860
P304
P356
10.1002/MDS.22839
P407
P577
2010-04-01T00:00:00Z